Key result
Study protocol outlines a multivariable prediction model for diagnosing early childhood myocarditis.
Why the study?
Paediatric myocarditis often lacks clear early symptoms, cardiac troponin I has low specificity, and cardiac biopsy is unsuitable for children, making accurate early-stage diagnosis challenging.
Can a prediction model using clinical, laboratory, and imaging data accurately diagnose early childhood myocarditis in patients under 14 years old?
Cohort (n=450)
No
Can a prediction model using clinical, laboratory, and imaging data accurately diagnose early childhood myocarditis in patients under 14 years old?
This protocol outlines the planned development and internal validation of a clinical prediction model to improve the early and accurate diagnosis of myocarditis in young children.
Protocol for pediatric myocarditis prediction model published; leaves open diagnostic accuracy and net benefit pending validation.
INTRODUCTION: Paediatric myocarditis, a rare inflammatory disease, often presents without clear early symptoms. Although cardiac troponin I levels can aid in diagnosing myocarditis, they are not definitive indicators. Troponin I levels frequently fluctuate within and outside the reference range, potentially causing misinterpretations by clinicians. Although a negative troponin I result is valuable for excluding myocarditis, its specificity is low. Moreover, the clinical diagnosis of paediatric myocarditis is exceptionally challenging, and accurate early-stage diagnosis and treatment pose difficulties. Currently, the Dallas criteria, involving cardiac biopsy, serves as the gold standard for myocarditis diagnosis. However, this method has several drawbacks and is unsuitable for children, resulting in its limited use. METHODS AND ANALYSIS: In this study, we will employ multiple logistic regression analysis to develop a predictive model for early childhood myocarditis. This model will assess the patient's condition at onset and provide the probability of a myocarditis diagnosis. Model performance will be evaluated for accuracy and calibration, and the results will be presented through receiver operating characteristic (ROC) curves and calibration plots. Clinical decision curve analysis, in conjunction with ROC curve analysis, will be employed to determine the optimal cut-off value and calculate the net clinical benefit value for assessing clinical effectiveness. Finally, internal model validation will be conducted using bootstrapping. ETHICS AND DISSEMINATION: Approval from the Clinical Research Ethics Committee of The Third Affiliated Hospital of Wenzhou Medical University has been obtained. The research findings will be disseminated through presentations at scientific conferences and publication in peer-reviewed journals.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2023) conducted a cohort in Childhood myocarditis (n=450). Clinical, laboratory, and imaging predictors vs. Children with suspected myocarditis who did not develop the condition was evaluated on Probability of myocarditis diagnosis. This paper describes a study protocol to develop a multivariable prediction model for early childhood myocarditis; no clinical results are reported.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: